Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: A controlled study

Circulation

Volumn 100, Issue 17, 1999, Pages 1798-1801

  Di Girolamo, Enrico ^a,b   Di Iorio, Cesare ^a   Leonzio, Luigi ^a   Sabatini, Panfilo ^a   Barsotti, Antonio ^a  

^a SS Annunziata Hospital   (Italy)

^b Cardiosurgical Department   (Italy)

Author keywords

Baroreceptors; Nervous system, autonomic; Reflex; Syncope

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLUDROCORTISONE; SEROTONIN UPTAKE INHIBITOR; VASOCONSTRICTOR AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRESSORECEPTOR; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; STANDING; SYMPTOM; SYNCOPE; TILT TABLE TEST; TRAINING; TREATMENT PLANNING;

EID: 0032732965     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.17.1798     Document Type: Article

References (23)

1. Day SC, Cook EF, Fundenstein H, Goldman L. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med. 1982;72:15-23.
2. Kenny RA, Bayliss J, Ingram A, Sutton R. Head-up tilt: a useful test for investigating unexplained syncope. Lancet. 1986;1:1352-1354.
3. Benditt DG, Ferguson DW, Grubb BP, Kapoor WN, Kugler J, Lerman BB, Maloney JD, Raviele A, Ross B, Sutton R, Wolk MJ, Wod DL. Tilt table testing for assessing syncope. J Am Coll Cardiol. 1996;28:263-275.
4. Abboud FM. Neurocardiogenic syncope. N Engl J Med. 1993;328: 1117-1120.
5. Kosinski D, Grubb BP, Temesy-Armos P. Pathophysiological aspects of neurocardiogenic syncope: current concepts and new perspectives. Pacing Clin Electrophysiol. 1995;18:716-724.
6. Morillo CA, Eckberg DL, Ellenbogen KA, Beightol LA, Hoag JB, Tahvanainen KUO, Kuusela TA, Diedrich AM. Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope. Circulation. 1997;96:2509-2513.
7. Rea R, Thames MD. Neural control mechanisms and vasovagal syncope. J Cardiovasc Electrophysiol. 1993;4:587-595.
8. Chosy JJ, Graham DT. Catecholamines in vasovagal fainting. J Psychosom Res. 1965;9:189-194.
9. Wallbridge DR, MacIntyre HE, Gray CE, Oldroyd KG, Rae AP, Cobbe SM. Role of endogenous opioids and catecholamines in vasovagal syncope. Eur Heart J. 1996;17:1729-1736.
10. Sakuma I, Togashi H, Yoshioka M. N-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone. Circ Res. 1992;70:607-611.
11. Shen WK, Hammil SC, Munger TM, Stanton MS, Packer DL, Osborn MJ, Wood DL, Bailey KR, Low PA, Gersh BJ. Adenosine. Potential modulator of vasovagal syncope. J Am Coll Cardiol. 1996;28:146-154.
12. Grubb BP, Wolfe DA, Samoil D, Temesy-Armos P, Hahn H, Elliot L. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. Pacing Clin Electrophysiol. 1993;16:458-464.
13. Grubb BP, Samoil D, Kosinski D, Kip K, Brewster P. Use of sertraline in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol. 1994;24:490-494.
14. Di Girolamo E, Di Iorio C, Sabatini P, Leonzio L, Barbone C, Barsotti A. Effects of paroxetine hydrochloride, a selective serotonin re-uptake inhibitor, on refractory vasovagal syncope: a randomized double-blind, placebo-controlled study. J Am Coll Cardiol. 1999;33:1227-1230.
15. Di Girolamo E, Di Iorio C, Sabatini P, Leonzio L, Barsotti A. Effects of different treatments vs no treatment on neurocardiogenic syncope. Cardiologia. 1998;43:833-837.
16. Ector H, Reybrouck T, Heidbüchel H, Gelliwig M, Van de Werf F. Tilt training: a new treatment for recurrent neurocardiogenic syncope and severe orthostatic intolerance. Pacing Clin Electrophysiol. 1998;21: 193-196.
17. Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol. 1991;17:125-130.
18. Raviele A, Menozzi C, Brignole M, Gasparini G, Alboni P, Musso G, Lolli G, Oddone D, Dinelli M, Mureddu R. Value of head-up tilting test potentiated with sublingual nitroglycerin to asses the origin on unexplained syncope. Am J Cardiol. 1995;76:267-272.
19. Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P. A proposed classification for tilt induced vasovagal syncope. Eur J Cardiol Pacing Electrophysiol. 1992;3:180-183.
20. Natale A, Sra J, Dhala A, Wase A, Jazayeri M, Deshpande S, Blanck Z, Akhtar M. Efficacy of different treatment strategies for neurocardiogenic syncope. Pacing Clin Electrophysiol. 1995;18:655-662.
21. Cox MM, Perlman BA, Mayor MR, Silberstein TA, Levin E, Pringle L, Castellanos A, Myerburg RJ. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol. 1995;26:1293-1298.
22. Morillo CA, Leitch JW, Yee R, Klein GJ. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol. 1993;22:1843-1848.
23. Sra J, Maglio C, Biehl M, Dhala A, Blanck Z, Deshpande S, Jazayeri MR, Akhtar M. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy. J Cardiovasc Electrophysiol. 1997;8:42-46.